Myrbetriq® (mirabegron) – First-time generic launch halted
April 23, 2024 - The Federal Circuit court issued a temporary injunction halting Lupin and Zydus launch of AB-rated generic versions of Astellas’ Myrbetriq (mirabegron) 25 mg extended-release tablets.
Download PDF
